A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs.
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004806:Ependymoma / Q000188:drug therapy*; D005492:Folic Acid / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009154:Mutation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D009607:Nitrosourea Compounds; D011687:Purines; D013256:Steroids; D005492:Folic Acid